Year: 2024

Til orientering er der dags dato indkaldt til ekstraordinær generalforsamling den 10. december 2024 hos foreningens forvalter, hvor dagsordenen omhandler en indstilling om navneændring fra Investeringsforvaltningsselskabet SEBinvest A/S til Wealth Fund Partners A/S samt en bestyrelsesændring.    De foreslåede ændringer hos foreningens forvalter har ingen praktisk påvirkning for dig som investor i Kapitalforeningen Wealth Invest. For mere information henvises til forvalters hjemmeside, https://seb.dk/virksomheder-og-institutioner/sebinvest   For eventuelle spørgsmål kan Lise Bøgelund Jensen, direktør i foreningens forvalter, kontaktes på telefon 33 28 28 28.  

New PMUX02 Power MUX Features High Switch Density and Expanded Voltage Range to Optimize Test of High-Current DevicesPMUX02Advanced power multiplexer for V93000 EXA scale test platformTOKYO, Nov. 19, 2024 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) today announced a new power multiplexer developed specifically for use on the V93000 EXA Scale SoC test platform. The PMUX02 Power MUX offers unprecedented capabilities for multi-site testing of power and analog devices, including battery management systems (BMS), automotive, and power management ICs. With 22 switches – nearly double the switch density of its predecessor – and an extended voltage range of ±160 volts (V), PMUX02 will help streamline and reduce the cost-of-test for these high-pin-count, mixed-signal devices. A...

LONDON and RALEIGH, N.C., Nov. 19, 2024 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that senior management will present a company overview at the following conferences in December 2024: Piper Sandler 36th Annual Healthcare ConferenceDate: Tuesday, December 3, 2024Time: 12:00 p.m. ET / 5:00 p.m. GMTLocation: New York, NY 7th Annual Evercore HealthCONx ConferenceDate: Wednesday, December 4, 2024Time: 3:00 p.m. ET / 8:00 p.m. GMTLocation: Miami, FL A webcast of each conference presentation will be available on the Events and Presentations link on the Investors page of the Company’s website, www.veronapharma.com. For further information please contact:   Verona Pharma plc Tel: +1-844-341-9901Victoria Stewart, Senior Director of Investor Relations and Communications IR@veronapharma.comArgot...

Bermuda, November 19, 2024, Avance Gas Holding Ltd. (ticker “AGAS”) will on Wednesday November 27, 2024, release its unaudited results for the third quarter of 2024. In connection with the earnings release, an audio webcast and conference call will be held at 14:00 (CEST). The presentation and webcast link will be available from the Investor Relation section at Avance Gas’ website www.avancegas.com prior the presentation and available by using the following links: Webcast:  https://edge.media-server.com/mmc/p/j6q2r66p Conference call:  https://register.vevent.com/register/BId9585c6a8c7a46fdaad8f2f978059a2d A Q&A session will be held after the conference call/webcast. For further queries, please contact: Randi Navdal Bekkelund, CFO Telephone: +47 23 11 40 00 Email: IR@avancegas.com ABOUT AVANCE GAS: Avance Gas...

Green Arrow selects Voltalia to build a power plant in Spain Voltalia (Euronext Paris, ISIN code: FR0011995588), an international player in renewable energies, announces the signing of a contract with Green Arrow Capital for the Engineering, Procurement and Construction (EPC) and Operation & Maintenance (O&M) of a 135-megawatt solar power plant The plant will be located in Seville (Andalusia), in the municipality of Sanlucar la Mayor. Construction will start in 2024, with full commissioning scheduled for 2025. Voltalia will then operate and maintain the plant for at least two years. Covering an area of 169 hectares, the plant will include 192,864 photovoltaic panels with a total capacity of 135 megawatts. Green Arrow Capital is a leading investor focused on renewable energy and other alternative investments in the real economy...

Azerion announces an update to its Supervisory Board and new additions to its Executive Committee Amsterdam, 19 November 2024 – Azerion announces today that Mr Chris Figee, Chairman of the Audit and Risk Committee and Supervisory Board Member, will be stepping down from his roles with Azerion with effect from the end of November 2024. This is due to Mr Figee’s additional commitments and responsibilities as CFO and Supervisory Board member of other firms. With effect from the end of November 2024 Mr Benjamin van de Vrie has been appointed to succeed Mr Figee as Chairman of the Audit and Risk Committee with Mrs Katrin Brökelmann to continue in her role as member of the Audit and Risk Committee. Mr Zafer Karataş will continue as Chairman of the Remuneration Committee. Commenting on these developments, Mr Wim de Pundert, Chairman of...

Ex dividend USD 0.0625 today The shares in BW Offshore Limited will trade ex dividend USD 0.0625 per share as from today, 19 November 2024. Dividend payment to shareholders will be on or about 27 November 2024. This information is published in accordance with the requirements of the Continuing Obligations. IR@bwoffshore.com   www.bwoffshore.com About BW Offshore: BW Offshore engineers innovative floating production solutions. The Company has a fleet of 3 FPSOs with potential and ambition to grow. By leveraging four decades of offshore operations and project execution, the Company creates tailored offshore energy solutions for evolving markets world-wide. BW Offshore has around 1,200 employees and is publicly listed on the Oslo stock exchange. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian...

Grant supports the first clinical trials studying the potential for brain-computer interface (BCI) and artificial intelligence (AI) technology to restore thought-driven movement after stroke Funding also supports technology development of ARC-BCI System and ARC-IM Lead Approximately 15 million people worldwide experience a stroke each year EINDHOVEN, the Netherlands, Nov. 19, 2024 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces a grant from the European Innovation Council (EIC) to study the use of its investigational ARC-BCI Therapy to restore upper limb movement after subcortical stroke. “While helping people with spinal cord...